Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Anne Goriely and Prof Alison Simmons, who have both been awarded Wellcome Trust Investigator Awards.

Anne Goriely is an Associate Professor of Human Genetics at the Radcliffe Department of Medicine. Her award will support a research programme focusing on a process called selfish selection, promoting clonal expansion of pathogenic de novo mutations in human testes/male germline. De novo mutations are widely thought to occur randomly. However, the group has challenged this assumption by showing that so-called selfish mutations are able to hijack the cellular control of male germline stem cells in which they arise, leading to their preferential transmission to the next generation. The Goriely group will use state-of-the-art technology to assess the significance of selfish selection for human disease and genome evolution.

Alison Simmons is a Professor of Gastroenterology at the Nuffield Department of Medicine and MRC Human Immunology Unit, and was recently elected a Fellow of the Academy of Medical Sciences. The Simmons lab works on Inflammatory Bowel Disease (IBD), a debilitating condition that affects more than 300,000 people in the UK. In IBD, the protective barrier that separates gut luminal microbes from the mucosal immune system is disrupted, leading to inflammation. Recently, the group used single cell technologies to chart the diverse cell types making up the gut mucosal barrier, uncovering new cell types and key pathways of barrier defence. The new Wellcome Investigator Award will define the relationships and signalling between these myriad cell types of the barrier and explore how these can be harnessed to promote intestinal health.

Recent stories

Immune sensor can detect viral infection by monitoring cell’s own RNA

A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.